Annals of Tropical Medicine and Public Health
Home About us Ahead Of Print Instructions Submission Subscribe Advertise Contact e-Alerts Editorial Board Login 
Users Online:1934
  Print this page  Email this page Small font sizeDefault font sizeIncrease font size
 


 
Table of Contents   
LETTER TO THE EDITOR  
Year : 2015  |  Volume : 8  |  Issue : 1  |  Page : 19
Melatonin treatment for Ebola virus disease


1 Wiwanitkit House, Bangkhae, Bangkok, Thailand
2 Hainan Medical University, China; University of Nis, Serbia; Joseph Ayobabalola University, Nigeria; Dr. DY Patil Medical University, India

Click here for correspondence address and email

Date of Web Publication8-May-2015
 

How to cite this article:
Wiwanitkit S, Wiwanitkit V. Melatonin treatment for Ebola virus disease. Ann Trop Med Public Health 2015;8:19

How to cite this URL:
Wiwanitkit S, Wiwanitkit V. Melatonin treatment for Ebola virus disease. Ann Trop Med Public Health [serial online] 2015 [cited 2019 Aug 18];8:19. Available from: http://www.atmph.org/text.asp?2015/8/1/19/156723
Dear Sir,

The new concept for using "Melatonin treatment for Ebola virus disease" is very interesting. Tan et al. reported that "melatonin has been successfully employed for the treatment of sepsis in many experimental and clinical studies" and it is possible that it might be applicable for the treatment of Ebola virus infection. [1] Indeed, a previous report by Galley et al. showed that the usefulness of melatonin in the management of sepsis is related to its "beneficial effects on sepsis-induced mitochondrial dysfunction, oxidative stress, and cytokine responses." [2]

There are some evidences that melatonin might be useful in the management of some viral infections such as "Venezuelan equine encephalomyelitis virus and respiratory syncytial virus." [3] Step-by-step modification of the cytokine system that is the problem in viral infection is believed to be the explanation for the usefulness of melatonin. [3] However, there is no evidence that melatonin can be useful in the management of hemorrhagic episode, which is the main problem that can lead to death in patients infected with Ebola virus. Based on the well-known viral hemorrhagic fever dengue, the standard management is fluid replacement therapy and the use of melatonin has never been effective. [4] The rapid leakage of fluid might be more serious than that of the compensation property of melatonin.

 
   References Top

1.
Tan DX, Korkmaz A, Reiter RJ, Manchester LC. Ebola virus disease: Potential use of melatonin as a treatment. J Pineal Res 2014;57:381-4.  Back to cited text no. 1
    
2.
Galley HF, Lowes DA, Allen L, Cameron G, Aucott LS, Webster NR. Melatonin as a potential therapy for sepsis: A phase I dose escalation study and an ex vivo whole blood model under conditions of sepsis. J Pineal Res 2014;56:427-38.  Back to cited text no. 2
    
3.
Vielma JR, Bonilla E, Chacín-Bonilla L, Mora M, Medina-Leendertz S, Bravo Y. Effects of melatonin on oxidative stress, and resistance to bacterial, parasitic, and viral infections: A review. Acta Trop 2014;137:31-8.  Back to cited text no. 3
    
4.
Wiwanitkit V. Dengue fever: Diagnosis and treatment. Expert Rev Anti Infect Ther 2010;8:841-5.  Back to cited text no. 4
    

Top
Correspondence Address:
Dr. Somsri Wiwanitkit
Wiwanitkit House, Bangkhae, Bangkok -10160, Thailand

Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/1755-6783.156723

Rights and Permissions




 

Top
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Email Alert *
    Add to My List *


    References

 Article Access Statistics
    Viewed719    
    Printed21    
    Emailed0    
    PDF Downloaded14    
    Comments [Add]    

Recommend this journal